【摘要】：目的:測(cè)定食管鱗癌患者Period 1(PER1)、Period 2(PER2)和VEGF(vascular endothelial growth factor,VEGF)在食管鱗癌患者中的異常表達(dá)與臨床病理的關(guān)系。了解腫瘤組織中節(jié)律基PER1、PER2與節(jié)律相關(guān)基因VEGF表達(dá)的相關(guān)性。了解食管鱗癌患者血清、尿液中VEGF的波動(dòng)規(guī)律及其與正常對(duì)照人群血液中VEGF波動(dòng)差異。方法:(1)RT-PCR法檢測(cè)3例食管鱗癌患者的正常組織、癌旁非典型增生組織及癌組中PER1、PER2和VEGF mRNA表達(dá)水平。(2)、Western-Blot法檢測(cè)食管鱗癌患者的正常組織、癌旁非典型增生組織及癌組織中VEGF、PER1和PER2蛋白表達(dá)水平。(3)、收集144例食管鱗癌患者的癌組織、癌旁組織及正常組織、患者血液標(biāo)本及臨床病例特點(diǎn)。免疫組化方法檢測(cè)144例食管鱗癌患者的癌組織、癌旁組織及正常組織中PER1、PER2和VEGF蛋白表達(dá)水平并觀察PER、PER2和VEGF與臨床特征的相關(guān)性。(4)、ELISA方法檢測(cè)144例患者血液中VEGF的表達(dá)情況。(5)、收集9位食管鱗癌患者四個(gè)時(shí)間點(diǎn)(03:00,09:00,15:00,21:00)血液和尿液標(biāo)本以及9位正常對(duì)照四個(gè)時(shí)間點(diǎn)(03:00,09:00,15:00,21:00)血液標(biāo)本。ELISA方法檢測(cè)9位食管鱗癌患者四個(gè)時(shí)間點(diǎn)(03:00,09:00,15:00,21:00)血液和尿液標(biāo)本中VEGF的表達(dá)量以及9位正常人血液中VEGF的表達(dá)量了解VEGF節(jié)律波動(dòng)的規(guī)律。結(jié)果:(1)RT-PCR、WB檢測(cè)結(jié)果顯示VEGF、PER1和PER2在食管鱗癌患者癌組織、癌旁非典型增生組織及正常組織中的表達(dá)存在差異,VEGF在癌組織、癌旁非典型增生組織中表達(dá)較正常組織高,PER1和PER2在腫瘤組織、癌旁非典型增生組織中表達(dá)較正常組織低。(2)、PER1、PER2蛋白在食管鱗癌患者腫瘤組織中的表達(dá)與腫瘤組織的的臨床分期、浸潤(rùn)深度、淋巴結(jié)轉(zhuǎn)移、遠(yuǎn)處轉(zhuǎn)移成負(fù)相關(guān),與分化程度呈正相關(guān);同時(shí)也觀察到腫瘤組織越靠近食管下段,其PER1、PER2的表達(dá)越低;而與性別、年齡、文化程度、腫瘤大小不相關(guān)。腫瘤組織中、血液中VEGF蛋白的表達(dá)與腫瘤組織的大小、臨床分期、浸潤(rùn)深度、淋巴結(jié)轉(zhuǎn)移、遠(yuǎn)處轉(zhuǎn)移成正相關(guān),與分化程度呈負(fù)相關(guān);同時(shí)也觀察到腫瘤組織越靠近食管下段,其VEGF蛋白的表達(dá)越低。而與性別、年齡、文化程度不相關(guān)。腫瘤組織中PER1、PER2蛋白的表達(dá)與腫瘤組織中、血液中VEGF蛋白表達(dá)呈負(fù)相關(guān)。(3)、正常人血液與食管鱗癌患者尿液、血液中VEGF的表達(dá)呈日節(jié)律波動(dòng),且正常人與食管鱗癌患者一天四個(gè)時(shí)間點(diǎn)VEGF的波動(dòng)幅度存在差異。結(jié)論:(1)、節(jié)律基因PER1和PER2的低表達(dá)與VEGF的高表達(dá)在食管鱗癌的發(fā)生與發(fā)展中起了重要作用。(2)、節(jié)律基因PER1和PER2的表達(dá)水平影響了VEGF表達(dá)及波動(dòng)情況。
[Abstract]:Aim: to investigate the relationship between the abnormal expression of Period 1 (PER1), Period 2 (PER2) and VEGF (vascular endothelial growth factor,VEGF) and clinicopathology in patients with esophageal squamous cell carcinoma. To investigate the relationship between rhythmic PER1,PER2 and rhythm related gene VEGF expression in tumor tissues. To investigate the fluctuation of VEGF in serum and urine of patients with esophageal squamous cell carcinoma and the difference of VEGF in blood between patients with esophageal squamous cell carcinoma and normal controls. Methods: (1) the expression of PER1,PER2 and VEGF mRNA in normal tissues, paracancerous atypical hyperplasia tissues and cancer groups were detected by RT-PCR. (2) the normal tissues of patients with esophageal squamous cell carcinoma were detected by Western-Blot. The expression levels of VEGF,PER1 and PER2 protein in paracancerous atypical hyperplasia and cancer tissues were collected. (3) the characteristics of cancer tissues, paracancerous tissues and normal tissues, blood samples and clinical cases were collected. The expression of PER1,PER2 and VEGF proteins in cancer tissues, paracancerous tissues and normal tissues of 144 patients with esophageal squamous cell carcinoma were detected by immunohistochemical method, and the correlation between PER,PER2 and VEGF and clinical features was observed. (4), The expression of VEGF in blood of 144 patients was detected by ELISA. (5), Blood and urine samples were collected from 9 patients with esophageal squamous cell carcinoma at four time points (0.3, 09, 15, 21) and 9 normal controls at four time points (0.3, 09, 15, 21). Elisa was used to detect 9 food. The expression of VEGF in blood and urine samples and the expression of VEGF in 9 normal subjects at four time points (03: 00, 09: 00, 15: 00, 21: 00) in patients with tubular squamous cell carcinoma understood the fluctuation of VEGF rhythm. Results: (1) the results of RT-PCR,WB showed that there were differences in the expression of VEGF,PER1 and PER2 in cancer tissues, atypical hyperplasia tissues and normal tissues, and the expression of VEGF was different in cancer tissues. The expression of PER1 and PER2 in paracancerous atypical hyperplasia tissues was higher than that in normal tissues. (2) PER1, was lower in tumor tissues and paracancerous atypical hyperplasia tissues than in normal tissues. The expression of PER2 protein in esophageal squamous cell carcinoma was negatively correlated with the clinical stage, depth of invasion, lymph node metastasis and distant metastasis, and positively correlated with the degree of differentiation. At the same time, it was also observed that the closer the tumor tissue was to the lower esophageal segment, the lower the expression of PER1,PER2 was, but not related to sex, age, educational level and tumor size. In tumor tissues, the expression of VEGF protein in blood was positively correlated with the size of tumor tissue, clinical stage, depth of invasion, lymph node metastasis and distant metastasis, but negatively correlated with the degree of differentiation. At the same time, the closer the tumor tissue was to the lower esophageal segment, the lower the expression of VEGF protein was. It is not related to sex, age and educational level. The expression of PER1,PER2 protein in tumor tissue was negatively correlated with the expression of VEGF protein in blood. (3) the expression of VEGF in urine and blood of normal human blood and esophageal squamous cell carcinoma patients fluctuated in daily rhythm. There was significant difference in the fluctuation range of VEGF between normal subjects and patients with esophageal squamous cell carcinoma at four time points a day. Conclusion: (1) the low expression of rhythm genes PER1 and PER2 and the high expression of VEGF play an important role in the occurrence and development of esophageal squamous cell carcinoma. (2) the expression of rhythm genes PER1 and PER2 affects the expression and fluctuation of VEGF.
【學(xué)位授予單位】：川北醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2016
【分類號(hào)】：R735.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張鵬,王雨生,張星,惠延年,胡丹,馬吉獻(xiàn);缺氧對(duì)人視網(wǎng)膜色素上皮細(xì)胞增生和VEGF表達(dá)的影響[J];眼科新進(jìn)展;2004年01期

2 黃欣,溫玉明,李龍江;外周血VEGF表達(dá)水平與舌癌頸淋巴結(jié)轉(zhuǎn)移關(guān)系的臨床研究[J];實(shí)用口腔醫(yī)學(xué)雜志;2004年03期

3 于曉紅;楊穎;周亞濱;;益心定悸方含藥血清對(duì)人臍靜脈內(nèi)皮細(xì)胞VEGF表達(dá)影響的研究[J];天津中醫(yī)藥大學(xué)學(xué)報(bào);2013年02期

4 郭惠蘭,謝華,謝東北,劉錫儀,黃紹軒;兔骨髓間充質(zhì)干細(xì)胞分化成骨及VEGF表達(dá)[J];解剖學(xué)研究;2003年04期

5 鐘麗紅;魏春敏;李魯楊;;益腦顆粒對(duì)衰老慢性腦缺血大鼠腦組織中VEGF表達(dá)的影響[J];中國(guó)老年學(xué)雜志;2009年10期

6 劉利利;;3日齡大鼠缺氧缺血性腦損傷腦組織VEGF表達(dá)變化探討[J];中國(guó)醫(yī)學(xué)創(chuàng)新;2012年20期

7 趙煒,王雨生,張瑞,張鵬,惠延年;p42/p44 MAPK信號(hào)轉(zhuǎn)導(dǎo)通路在缺氧誘導(dǎo)的人視網(wǎng)膜色素上皮細(xì)胞VEGF表達(dá)中的作用[J];眼科新進(jìn)展;2005年02期

8 蘭蘭;王雨生;王耀春;張鵬;;磷脂酰肌醇-3激酶信號(hào)通路在缺氧誘導(dǎo)的人視網(wǎng)膜色素上皮細(xì)胞VEGF表達(dá)中的作用[J];國(guó)際眼科雜志;2006年03期

9 程琦;宋文剛;王寧;張延新;張印坡;;類風(fēng)濕性關(guān)節(jié)炎滑膜組織中VEGF表達(dá)及臨床意義[J];中國(guó)當(dāng)代醫(yī)藥;2011年25期

10 吳云剛,童培建,肖魯偉,馬鎮(zhèn)川;激素性股骨頭壞死介入治療過程中VEGF表達(dá)的實(shí)驗(yàn)研究[J];中國(guó)中醫(yī)骨傷科雜志;2002年04期

相關(guān)會(huì)議論文 前10條

1 勵(lì)建安;黃澎;袁紅潔;;有氧訓(xùn)練對(duì)慢性冠狀動(dòng)脈狹窄豬心肌VEGF表達(dá)的影響[A];2002年第9屆全國(guó)運(yùn)動(dòng)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文摘要匯編[C];2002年

2 葉群如;彭清華;張波濤;;蠐螬對(duì)實(shí)驗(yàn)性視網(wǎng)膜靜脈阻塞兔VEGF表達(dá)的影響及意義[A];中華中醫(yī)藥學(xué)會(huì)第七次眼科學(xué)術(shù)交流會(huì)論文匯編[C];2008年

3 蔣紅芝;黃光英;張明敏;;針刺對(duì)局部腦缺血大鼠VEGF表達(dá)和腦血流的影響[A];全國(guó)血栓/止血與微循環(huán)學(xué)術(shù)會(huì)議論文匯編[C];2006年

4 陸化;胡慧瑾;李俊霞;費(fèi)小明;李建勇;;硼替佐米對(duì)骨髓間充質(zhì)干細(xì)胞VEGF表達(dá)影響的研究[A];第13屆全國(guó)實(shí)驗(yàn)血液學(xué)會(huì)議論文摘要[C];2011年

5 嚴(yán)瑞蘭;辛?xí)匝?王健;王德堂;錢新華;金明;惠宏襄;;抗VEGF發(fā)卡狀核酶基因抑制VEGF表達(dá)及卵巢癌細(xì)胞增殖的實(shí)驗(yàn)研究[A];中國(guó)抗癌協(xié)會(huì)婦科腫瘤專業(yè)委員會(huì)第六次全國(guó)學(xué)術(shù)會(huì)議論文匯編[C];2001年

6 孫善珍;張曉英;宋纓;王霞;楊美香;曲迅;;缺氧對(duì)人Tca8113細(xì)胞HIF-1α、VEGF表達(dá)水平的影響[A];中華口腔醫(yī)學(xué)會(huì)第七屆全國(guó)口腔病理學(xué)術(shù)會(huì)議論文摘要匯編[C];2006年

7 連方;劉海萍;王云霞;張建偉;孫振高;馬鳳梅;張寧;劉延荷;孟茜;;子宮內(nèi)膜異位癥在位內(nèi)膜VEGF和Ki-67的表達(dá)及祛瘀解毒方對(duì)在位內(nèi)膜VEGF表達(dá)的影響[A];全國(guó)中醫(yī)婦科第六次學(xué)術(shù)研討會(huì)論文匯編[C];2006年

8 李飛;李樹清;;不同腦溫對(duì)樹，

本文編號(hào)：2475121